Fungal and bacterial gut microbiota differ between Clostridioides difficile colonization and infection

Abstract

Aim: The bacterial microbiota is well-recognized for its role in Clostridioides difficile colonization and infection, while fungi and yeasts remain understudied. The aim of this study was to analyze the predictive value of the mycobiota and its interactions with the bacterial microbiota in light of C. difficile colonization and infection.

Methods: The mycobiota was profiled by ITS2 sequencing of fecal DNA from C. difficile infection (CDI) patients (n = 29), asymptomatically C. difficile colonization (CDC) patients (n = 38), and hospitalized controls with C. difficile negative stool culture (controls; n = 38). Previously published 16S rRNA gene sequencing data of the same cohort were used additionally for machine learning and fungal-bacterial network analysis.

Results: CDI patients were characterized by a significantly higher abundance of Candida spp. (MD 0.270 ± 0.089, P = 0.002) and Candida albicans (MD 0.165 ± 0.082, P = 0.023) compared to controls. Additionally, they were deprived of Aspergillus spp. (MD -0.067 ± 0.026, P = 0.000) and Penicillium spp. (MD -0.118 ± 0.043, P = 0.000) compared to CDC patients. Network analysis revealed a positive association between several fungi and bacteria in CDI and CDC, although the analysis did not reveal a direct association between Clostridioides spp. and fungi. Furthermore, the microbiota machine learning model outperformed the models based on the mycobiota and the joint microbiota-mycobiota model. The microbiota classifier successfully distinguished CDI from CDC [Area Under the Receiver Operating Characteristic (AUROC) = 0.884] and CDI from controls (AUROC = 0.905). Blautia and Bifidobacterium were marker genera associated with CDC patients and controls.

Conclusion: The gut mycobiota differs between CDI, CDC, and controls and may affect Clostridioides spp. through indirect interactions. The mycobiota data alone could not successfully discriminate CDC from controls or CDI patients and did not have additional predictive value to the bacterial microbiota data. The identification of bacterial marker genera associated with CDC and controls warrants further investigation.

Keywords

Mycobiota / fungi / gut microbiota / Clostridioides difficile / CDI

References

[1] Smits WK,Lacy DB,Kuijper EJ.Clostridium difficile infection.Nat Rev Dis Primers2016;2:16020

[2] Rea MC,Shanahan F.Clostridium difficile carriage in elderly subjects and associated changes in the intestinal microbiota.J Clin Microbiol2012;50:867-75

[3] Hopkins MJ.Changes in predominant bacterial populations in human faeces with age and with Clostridium difficile infection.J Med Microbiol2002;51:448-54

[4] Sehgal K.Gut microbiome and Clostridioides difficile infection: a closer look at the microscopic interface.Therap Adv Gastroenterol2021;14:1756284821994736

[5] Terveer EM,Ooijevaar RE.Faecal microbiota transplantation for Clostridioides difficile infection: four years’ experience of the Netherlands Donor Feces Bank.United European Gastroenterol J2020;8:1236-47

[6] Hvas CL,Jørgensen SP.Fecal microbiota transplantation is superior to fidaxomicin for treatment of recurrent Clostridium difficile infection.Gastroenterology2019;156:1324-32.e3

[7] Quraishi MN,Manzoor SE.The journey towards safely restarting faecal microbiota transplantation services in the UK during the COVID-19 era.Lancet Microbe2021;2:e133-4

[8] Wei S,Baunwall SMD.Gut microbiota differs between treatment outcomes early after fecal microbiota transplantation against recurrent Clostridioides difficile infection.Gut Microbes2022;14:2084306

[9] Baktash A,Zwittink RD.Mechanistic insights in the success of fecal microbiota transplants for the treatment of Clostridium difficile infections.Front Microbiol2018;9:1242

[10] Khoruts A.Understanding the mechanisms of faecal microbiota transplantation.Nat Rev Gastroenterol Hepatol2016;13:508-16

[11] Szajewska H.Systematic review with meta-analysis: saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea.Aliment Pharmacol Ther2015;42:793-801

[12] Zhang Y,Feng H.The development of live biotherapeutics against Clostridioides difficile infection towards reconstituting gut microbiota.Gut Microbes2022;14:2052698

[13] Crobach MJT,Loo VG.Understanding Clostridium difficile colonization.Clin Microbiol Rev2018;31:e00021-17

[14] Eyre DW,Vaughan A.Asymptomatic Clostridium difficile Colonisation and Onward Transmission.PLoS One2013;8:e78445

[15] Kong LY,Corbeil J.Clostridium difficile: investigating transmission patterns between infected and colonized patients using whole genome sequencing.Clin Infect Dis2019;68:204-9

[16] Zacharioudakis IM,Pliakos EE,Mylonakis E.Colonization with toxinogenic C. difficile upon hospital admission, and risk of infection: a systematic review and meta-analysis.Am J Gastroenterol2015;110:381-90

[17] Blixt T,Homann C.Asymptomatic carriers contribute to nosocomial clostridium difficile infection: a cohort study of 4508 patients.Gastroenterology2017;152:1031-41.e2

[18] Rodríguez C,Garrido-Sanchez L.Microbiota insights in Clostridium difficile infection and inflammatory bowel disease.Gut Microbes2020;12:1725220

[19] Crobach MJT,Verduin C.Screening for Clostridioides difficile colonization at admission to the hospital: a multi-centre study.Clin Microbiol Infect2023;29:891-6

[20] Zhang F,Yoo JY.The gut mycobiome in health, disease, and clinical applications in association with the gut bacterial microbiome assembly.Lancet Microbe2022;3:e969-83

[21] Stewart Sr DB,Fowler M.Integrated meta-omics reveals a fungus-associated bacteriome and distinct functional pathways in clostridioides difficile infection.mSphere2019;4:e00454-19

[22] Cao Y,Ke S.Analysis of intestinal mycobiota of patients with clostridioides difficile infection among a prospective inpatient cohort.Microbiol Spectr2022;10:e0136222

[23] Cao Y,Ke S.Fecal mycobiota combined with host immune factors distinguish Clostridioides difficile infection from asymptomatic carriage.Gastroenterology2021;160:2328-39.e6

[24] Sangster W,Schieffer KM.Bacterial and fungal microbiota changes distinguish C. difficile infection from other forms of diarrhea: results of a prospective inpatient study.Front Microbiol2016;7:789

[25] Lamendella R,Hackman J.Antibiotic treatments for Clostridium difficile infection are associated with distinct bacterial and fungal community structures.mSphere2018;3:e00572-17

[26] Zuo T,Cheung CP.Gut fungal dysbiosis correlates with reduced efficacy of fecal microbiota transplantation in Clostridium difficile infection.Nat Commun2018;9:3663

[27] van Leeuwen PT,Bikker FJ.Interspecies interactions between Clostridium difficile and Candida albicans.mSphere2016;1:e00187-16

[28] Romo JA.Characterization of the effects of Candida gastrointestinal colonization on Clostridioides difficile infection in a murine model. In: Calderone R, editor. Candida species: methods in molecular biology. New York: Humana; 2022. pp. 271-85.

[29] Crobach MJT,Terveer EM.The bacterial gut microbiota of adult patients infected, colonized or noncolonized by Clostridioides difficile.Microorganisms2020;8:677

[30] Fawley WN,MacCannell DR.Development and validation of an internationally-standardized, high-resolution capillary gel-based electrophoresis PCR-ribotyping protocol for clostridium difficile.PLoS One2015;10:e0118150

[31] Rivers AR. Q2-ITSxpress: a tutorial on a QIIME 2 plugin to trim ITS sequences. Available from: https://forum.qiime2.org/t/q2-itsxpress-a-tutorial-on-a-qiime-2-plugin-to-trim-its-sequences/5780. [Last accessed on 5 Dec 2023]

[32] Bolyen E,Dillon MR.Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2.Nat biotechnol2019;37:852-7

[33] Rivers AR,Gardner TG,Armstrong SD.ITSxpress: software to rapidly trim internally transcribed spacer sequences with quality scores for marker gene analysis.F1000Res2018;7:1418

[34] Callahan BJ,Rosen MJ,Han AW,Holmes SP.DADA2: high-resolution sample inference from Illumina amplicon data.Nat Methods2016;13:581-3

[35] Abarenkov K,Piirmann T.UNITE QIIME release for eukaryotes.

[36] R Core Team. R: a language and environment for statistical computing. In: R Foundation for Statistical Computing; 2022. Available from: https://www.bibsonomy.org/bibtex/7469ffee3b07f9167cf47e7555041ee7. [Last accessed on 5 Dec 2023]

[37] Bisanz J. qiime2R: Importing QIIME2 artifacts and associated data into R sessions. Available from: https://rdrr.io/github/jbisanz/qiime2R/. [Last accessed on 5 Dec 2023]

[38] Wickham H.ggplot2: elegant graphics for data analysis. 2th ed. New York: Springer Cham; 2016.

[39] Ianiri G,Scheynius A.The skin commensal yeast Malassezia globosa thwarts bacterial biofilms to benefit the host.J Invest Dermatol2018;138:1026-9

[40] Sousa-Silva M,Soares P,Soares-Silva I.Expanding the knowledge on the skillful yeast Cyberlindnera jadinii.J Fungi2021;7:36

[41] Lahti L. microbiome R package. Available from: https://doi.org/10.18129/B9.bioc.microbiome. [Last accessed on 5 Dec 2023]

[42] McMurdie PJ.phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data.PLoS One2013;8:e61217

[43] Fernandes AD,Linn TG,Gloor GB.ANOVA-Like differential expression (ALDEx) analysis for mixed population RNA-Seq.PLoS One2013;8:e67019

[44] Kassambara A. ggpubr: ‘ggplot2’ based publication ready plots. Available from: https://rpkgs.datanovia.com/ggpubr/. [Last accessed on 5 Dec 2023]

[45] Wirbel J,Essex M.Microbiome meta-analysis and cross-disease comparison enabled by the SIAMCAT machine learning toolbox.Genome Biol2021;22:93

[46] Kurtz ZD,Miraldi ER,Blaser MJ.Sparse and compositionally robust inference of microbial ecological networks.PLoS Comput Biol2015;11:e1004226

[47] Pedersen TL. ggraph: an implementation of grammar of graphics for graphs and networks. Available from: https://rdrr.io/cran/ggraph/. [Last accessed on 5 Dec 2023]

[48] Manian FA.Does Candida species overgrowth protect against Clostridium difficile infection?.Clin Infect Dis2013;56:464-5

[49] Nerandzic MM,Miller MA,Donskey CJ.Reduced acquisition and overgrowth of vancomycin-resistant enterococci and Candida species in patients treated with fidaxomicin versus vancomycin for Clostridium difficile infection.Clin Infect Dis2012;55 Suppl 2:S121-6

[50] Markey L,Green ER.Pre-colonization with the commensal fungus Candida albicans reduces murine susceptibility to Clostridium difficile infection.Gut Microbes2018;9:497-509

[51] Kumamoto CA.Inflammation and gastrointestinal Candida colonization.Curr Opin Microbiol2011;14:386-91

[52] Blanco N,Malani AN.Clostridium difficile shows no trade-off between toxin and spore production within the human host.J Med Microbiol2018;67:631-40

[53] Raponi G,Brunetti G.Clostridium difficile Infection and Candida colonization of the gut: is there a correlation?.Clin Infect Dis2014;59:1648-9

[54] Gutierrez D,Antharam VC.Antibiotic-induced gut metabolome and microbiome alterations increase the susceptibility to Candida albicans colonization in the gastrointestinal tract.FEMS Microbiol Ecol2020;96:fiz187

[55] Seelbinder B,Brunke S.Antibiotics create a shift from mutualism to competition in human gut communities with a longer-lasting impact on fungi than bacteria.Microbiome2020;8:133

[56] Wombwell E.Saccharomyces boulardii prophylaxis for targeted antibiotics and infectious indications to reduce healthcare facility-onset Clostridioides difficile infection.Microbes Infect2023;25:105041

[57] van Prehn J,Vogelzang EH.European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults.Clin Microbiol Infect2021;27 Suppl 2:S1-21

[58] Berkell M,Xavier BB.Microbiota-based markers predictive of development of Clostridioides difficile infection.Nat Commun2021;12:2241

[59] Lesniak NA,Flynn KJ.The gut bacterial community potentiates Clostridioides difficile infection severity.mBio2022;13:e0118322

[60] Skraban J,Zenko B,Gangl S.Gut microbiota patterns associated with colonization of different Clostridium difficile ribotypes.PLoS One2013;8:e58005

[61] Jarocki P.Genetic diversity of bile salt hydrolases among human intestinal bifidobacteria.Curr Microbiol2013;67:286-92

[62] Song Z,Lao X.Taxonomic profiling and populational patterns of bacterial bile salt hydrolase (BSH) genes based on worldwide human gut microbiome.Microbiome2019;7:9

[63] Mullish BH,Pechlivanis A.Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent Clostridioides difficile infection.Gut2019;68:1791-800

[64] Brown JRM,Joyce SA.Changes in microbiota composition, bile and fatty acid metabolism, in successful faecal microbiota transplantation for Clostridioides difficile infection.BMC Gastroenterol2018;18:131

[65] Aguirre AM.Gut associated metabolites and their roles in Clostridioides difficile pathogenesis.Gut Microbes2022;14:2094672

[66] Takada T,Tsuji H.Fusicatenibacter saccharivorans gen. nov., sp. nov., isolated from human faeces.Int J Syst Evol Micr2013;63:3691-6

[67] Gibson CM,Naziruddin Z.The alteration of the gut microbiome by immunosuppressive agents used in solid organ transplantation.Transpl Infect Dis2021;23:e13397

[68] Huang J,Kang W.Effects of microbiota on anticancer drugs: current knowledge and potential applications.eBioMedicine2022;83:104197

[69] Nilsson RH,Bahram M.Mycobiome diversity: high-throughput sequencing and identification of fungi.Nat Rev Microbiol2019;17:95-109

[70] Kazemian N,Sehgal A.The trans-kingdom battle between donor and recipient gut microbiome influences fecal microbiota transplantation outcome.Sci Rep2020;10:18349

[71] Hernández Medina R,Nielsen KN.Machine learning and deep learning applications in microbiome research.ISME Commun2022;2:98

[72] Asnicar F,Passerini A,Segata N.Machine learning for microbiologists. Nat Rev Microbiol 2023.